CV
Chandra Vargeese
See Remarks

Chandra Vargeese insider trades: Wave Life Sciences (WVE) stock sales

See Remarks, Wave Life Sciences Last trade Feb 9, 2026 23 Form 4 filings
$43K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2017
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Chandra reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 9, 2026WVE↓ Sell$43K
Feb 16, 2023WVE↓ Sell$41K
May 5, 2022WVE↓ Sell$29K
Feb 16, 2022WVE↓ Sell$25K
Feb 16, 2021WVE↓ Sell$33K
Feb 18, 2020WVE↓ Sell$25K
Dec 3, 2019WVE↓ Sell$210K
Feb 19, 2019WVE↓ Sell$76K
Sep 24, 2018WVE↓ Sell$165K
Feb 15, 2018WVE↓ Sell$100K
Jan 23, 2018WVE↓ Sell$80K
Nov 22, 2017WVE↓ Sell$53K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other WVE insiders

Open-market trades in the last 12 months

About Chandra Vargeese's insider trades

Chandra Vargeese is See Remarks at Wave Life Sciences (WVE). Since Nov 22, 2017, Chandra has reported no open-market purchases and 12 sales worth $880K on SEC Form 4. In the last 12 months: 1 sale ($43K).

Their filings also include grants and awards (13 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WVE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.